Raymond James Financial Services Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-66,307
| Closed | -$2.09M | – | 3304 |
|
2023
Q2 | $2.09M | Sell |
66,307
-7,032
| -10% | -$222K | ﹤0.01% | 1489 |
|
2023
Q1 | $1.99M | Buy |
73,339
+489
| +0.7% | +$13.3K | ﹤0.01% | 1495 |
|
2022
Q4 | $2.21M | Sell |
72,850
-4,341
| -6% | -$132K | ﹤0.01% | 1383 |
|
2022
Q3 | $2.33M | Buy |
77,191
+836
| +1% | +$25.2K | 0.01% | 1341 |
|
2022
Q2 | $2.11M | Buy |
76,355
+48,592
| +175% | +$1.35M | ﹤0.01% | 1405 |
|
2022
Q1 | $934K | Buy |
27,763
+6,757
| +32% | +$227K | ﹤0.01% | 2004 |
|
2021
Q4 | $887K | Sell |
21,006
-1,158
| -5% | -$48.9K | ﹤0.01% | 2046 |
|
2021
Q3 | $1.01M | Sell |
22,164
-329
| -1% | -$15K | ﹤0.01% | 1950 |
|
2021
Q2 | $1.1M | Sell |
22,493
-43
| -0.2% | -$2.1K | ﹤0.01% | 1884 |
|
2021
Q1 | $1.13M | Buy |
22,536
+1,371
| +6% | +$68.9K | ﹤0.01% | 1766 |
|
2020
Q4 | $1.08M | Sell |
21,165
-902
| -4% | -$46.2K | ﹤0.01% | 1647 |
|
2020
Q3 | $908K | Buy |
22,067
+935
| +4% | +$38.5K | ﹤0.01% | 1608 |
|
2020
Q2 | $884K | Sell |
21,132
-144
| -0.7% | -$6.02K | ﹤0.01% | 1569 |
|
2020
Q1 | $674K | Buy |
21,276
+394
| +2% | +$12.5K | ﹤0.01% | 1384 |
|
2019
Q4 | $883K | Buy |
20,882
+808
| +4% | +$34.2K | ﹤0.01% | 1612 |
|
2019
Q3 | $634K | Buy |
20,074
+2,556
| +15% | +$80.7K | ﹤0.01% | 1746 |
|
2019
Q2 | $633K | Buy |
17,518
+1,900
| +12% | +$68.7K | ﹤0.01% | 1771 |
|
2019
Q1 | $565K | Buy |
15,618
+788
| +5% | +$28.5K | ﹤0.01% | 1815 |
|
2018
Q4 | $417K | Buy |
14,830
+2,143
| +17% | +$60.3K | ﹤0.01% | 1790 |
|
2018
Q3 | $499K | Buy |
12,687
+2,345
| +23% | +$92.2K | ﹤0.01% | 1914 |
|
2018
Q2 | $385K | Buy |
10,342
+1,105
| +12% | +$41.1K | ﹤0.01% | 2061 |
|
2018
Q1 | $316K | Buy |
9,237
+2,753
| +42% | +$94.2K | ﹤0.01% | 1996 |
|
2017
Q4 | $213K | Buy |
+6,484
| New | +$213K | ﹤0.01% | 2220 |
|